BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26194633)

  • 1. Plasmapheresis therapy in ANCA-associated vasculitides: A single-center retrospective analysis of renal outcome and mortality.
    Solar-Cafaggi D; Atisha-Fregoso Y; Hinojosa-Azaola A
    J Clin Apher; 2016 Oct; 31(5):411-8. PubMed ID: 26194633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: single-center results of stepwise escalation of immunosuppression.
    de Joode AA; Sanders JS; Smid WM; Stegeman CA
    J Clin Apher; 2014 Oct; 29(5):266-72. PubMed ID: 24497412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
    Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
    Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
    Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
    Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study.
    Sacri AS; Chambaraud T; Ranchin B; Florkin B; Sée H; Decramer S; Flodrops H; Ulinski T; Allain-Launay E; Boyer O; Dunand O; Fischbach M; Hachulla E; Pietrement C; Le Pogamp P; Stephan JL; Belot A; Nivet H; Nobili F; Guillevin L; Quartier P; Deschênes G; Salomon R; Essig M; Harambat J
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i104-12. PubMed ID: 25676121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study Group.
    de Luna G; Chauveau D; Aniort J; Carron PL; Gobert P; Karras A; Marchand-Adam S; Maurier F; Hatron PY; Mania A; le Guenno G; Bally S; Bienvenu B; Cardineau E; Goulenok T; Jourde-Chiche N; Samson M; Huart A; Pourrat J; Tiple A; Aumaitre O; Puéchal X; Heshmati F; le Jeunne C; Mouthon L; Guillevin L; Terrier B;
    J Autoimmun; 2015 Dec; 65():49-55. PubMed ID: 26330347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of ANCA-associated vasculitis with severe renal manifestation under routine conditions].
    Stille K; Kuipers JG; Herget-Rosenthal S
    Z Rheumatol; 2016 Nov; 75(9):910-916. PubMed ID: 26951194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of plasmapheresis performed in hemodialysis units for the treatment of anti-neutrophilic cytoplasmic antibody-associated systemic vasculitides.
    Aydin Z; Gursu M; Karadag S; Uzun S; Tatli E; Sumnu A; Ozturk S; Kazancioglu R
    Ther Apher Dial; 2011 Oct; 15(5):493-8. PubMed ID: 21974704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
    Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
    J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of plasmapheresis in ANCA clearance in patients with ANCA-associated vasculitides.
    Górka J; Polok K; Nowak I; Włudarczyk A; Sydor W; Padjas A; Sznajd J; Szczeklik W; Musiał J
    Przegl Lek; 2016; 73(7):445-7. PubMed ID: 29676884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advances in the treatment of antineutrophil cytoplasm antibody associated vasculitides].
    Szabó MZ; Pálfi P; Bazsó A; Poór G; Kiss E
    Orv Hetil; 2015 Oct; 156(41):1653-60. PubMed ID: 26551168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-neutrophil cytoplasmic antibody-associated vasculitis with renal involvement: Analysis of 89 cases.
    Caravaca-Fontán F; Yerovi E; Delgado-Yagu E M; Galeano C; Pampa-Saico S; Tenorio MT; Liaño F
    Med Clin (Barc); 2017 Jan; 148(1):1-7. PubMed ID: 28196580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study.
    Frausová D; Hrušková Z; Lánská V; Lachmanová J; Tesař V
    Arthritis Res Ther; 2016 Jul; 18():168. PubMed ID: 27412443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal vasculitis presenting with acute kidney injury.
    Villacorta J; Diaz-Crespo F; Acevedo M; Cavero T; Guerrero C; Praga M; Fernandez-Juarez G
    Rheumatol Int; 2017 Jun; 37(6):1035-1041. PubMed ID: 28289874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New advances in the pathogenesis of ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea.
    Ahn JK; Hwang JW; Lee J; Jeon CH; Cha HS; Koh EM
    Rheumatol Int; 2012 Oct; 32(10):2979-86. PubMed ID: 21898069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome and treatment of elderly patients with ANCA-associated vasculitis.
    Weiner M; Goh SM; Mohammad AJ; Hruskova Z; Tanna A; Bruchfeld A; Selga D; Chocova Z; Westman K; Eriksson P; Pusey CD; Tesar V; Salama AD; Segelmark M
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1128-35. PubMed ID: 26100457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease Activity and Adverse Events in Patients with ANCA-Associated Vasculitides Undergoing Long-Term Dialysis.
    Kauffmann M; Bobot M; Robert T; Burtey S; Couvrat-Desvergnes G; Lavainne F; Puéchal X; Terrier B; Quéméneur T; Faguer S; Karras A; Brunet P; Couchoud C; Jourde-Chiche N;
    Clin J Am Soc Nephrol; 2021 Nov; 16(11):1665-1675. PubMed ID: 34750159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis.
    Puéchal X; Pagnoux C; Perrodeau É; Hamidou M; Boffa JJ; Kyndt X; Lifermann F; Papo T; Merrien D; Smail A; Delaval P; Hanrotel-Saliou C; Imbert B; Khouatra C; Lambert M; Leské C; Ly KH; Pertuiset E; Roblot P; Ruivard M; Subra JF; Viallard JF; Terrier B; Cohen P; Mouthon L; Le Jeunne C; Ravaud P; Guillevin L;
    Arthritis Rheumatol; 2016 Mar; 68(3):690-701. PubMed ID: 26473755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Apheresis in the treatment of vasculitis].
    Somenzi D; Corradini M; Pasquali S
    G Ital Nefrol; 2012; 29 Suppl 54():S73-7. PubMed ID: 22388835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.